ICICI Securities Assigns Buy Rating to Jyothy Labs, Sets Price Target of Rs 310

Jyothy Labs Reports Robust Volume-Led Recovery in Q4FY26

Jyothy Labs, a leading Indian consumer goods company, has reported a strong volume-led recovery in its Q4FY26 performance, validating the company's strategy to defend and expand its market share. The company's revenue growth was driven by a robust 11% increase in volumes, which came at the expense of profitability. Despite the near-term margin squeeze, ICICI Securities views this development as a strategic investment in long-term market positioning.

Key Drivers of Growth

Jyothy Labs' expanding distribution footprint across modern trade (MT) and quick commerce (QC) has been a key driver of its growth. The company's successful expansion into these channels has secured a wider and more resilient revenue base. Although earnings compounding is expected to remain measured until price hikes are fully absorbed and input costs stabilize, the structural volume momentum is largely in place. The company is expected to deliver operating leverage once the commodity cycle normalizes.

Read also: Expert Portfolio Manager Raja Venkatraman Names Top Investment Picks for June 4

Financial Performance

Jyothy Labs remains debt-free with a cash chest of approximately INR 10 billion. The company is actively evaluating M&A targets, further enhancing its growth prospects.

Recommendation

Read also: MarketSmith India's 4 June Stock Recommendations

ICICI Securities maintains a BUY rating on Jyothy Labs with a DCF-based revised target price of INR 310 (INR 300 previously). At the target price, the stock could trade at 24x P/E multiple of Mar'28E, reflecting the company's strong growth prospects and market positioning.